Elaine Ku MD, MAS , Timothy P. Copeland PhD , Charles E. McCulloch PhD , Kaleab Z. Abebe PhD , Michel Chonchol MD , Ronald D. Perrone MD , Frederic F. Rahbari-Oskoui MD , Alan S.L. Yu MD , Theodore Steinman MD , Arlene Chapman MD , Mark J. Sarnak MD, MS
{"title":"双重 RAAS 阻断和强化降压对常染色体显性遗传多囊肾病终末期肾病和死亡风险的影响:HALT-PKD试验的长期随访。","authors":"Elaine Ku MD, MAS , Timothy P. Copeland PhD , Charles E. McCulloch PhD , Kaleab Z. Abebe PhD , Michel Chonchol MD , Ronald D. Perrone MD , Frederic F. Rahbari-Oskoui MD , Alan S.L. Yu MD , Theodore Steinman MD , Arlene Chapman MD , Mark J. Sarnak MD, MS","doi":"10.1053/j.ajkd.2024.06.020","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"85 1","pages":"Pages 127-130"},"PeriodicalIF":9.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials\",\"authors\":\"Elaine Ku MD, MAS , Timothy P. Copeland PhD , Charles E. McCulloch PhD , Kaleab Z. Abebe PhD , Michel Chonchol MD , Ronald D. Perrone MD , Frederic F. Rahbari-Oskoui MD , Alan S.L. Yu MD , Theodore Steinman MD , Arlene Chapman MD , Mark J. Sarnak MD, MS\",\"doi\":\"10.1053/j.ajkd.2024.06.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7419,\"journal\":{\"name\":\"American Journal of Kidney Diseases\",\"volume\":\"85 1\",\"pages\":\"Pages 127-130\"},\"PeriodicalIF\":9.4000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Kidney Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0272638624009223\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272638624009223","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials
期刊介绍:
The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.